Arotinolol Hydrochloride

盐酸阿罗洛尔

Report date: 2022/03/04 16:30:06
NME

Base Information

Drug NameArotinolol Hydrochloride
Drug Alias Namearotinololum盐酸噻吩洛尔Almarl阿尔马尔S-596
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors antagonistsAlpha adrenergic receptor antagonists
TargetsBeta adrenergic receptorsAlpha adrenergic receptor
Therapy Area/IndicationsHypertensionAngina PectorisArrhythmias, Cardiac
Global Approved IndicationsHypertensionAngina PectorisArrhythmias, Cardiac
Approved Indications in ChinaHypertensionAngina PectorisArrhythmias, Cardiac
Original Approved Country/TerritoryJapan
Original Approved Date1985/01/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesSumitomo Dainippon
Inactive CompaniesN/A
Active IndicationsHypertensionAngina PectorisArrhythmias, Cardiac
Inactive IndicationsN/A

Other Information

ATC CodeC07AB
Related LinksWikipediaDrugBankKEGG